Precision fluid and vasoactive drug therapy for critically ill patients.
Pharmacotherapy
; 43(11): 1182-1193, 2023 Nov.
Article
en En
| MEDLINE
| ID: mdl-36606689
ABSTRACT
There are several clinical practice guidelines concerning the use of fluid and vasoactive drug therapies in critically ill adult patients, but the recommendations in these guidelines are often based on low-quality evidence. Further, some were compiled prior to the publication of landmark clinical trials, particularly in the comparison of balanced crystalloid and normal saline. An important consideration in the treatment of critically ill patients is the application of precision medicine to provide the most effective care to groups of patients most likely to benefit from the therapy. Although not currently widely integrated into these practice guidelines, the utility of precision medicine in critical illness is a recognized research priority for fluid and vasoactive therapy management. The purpose of this narrative review was to illustrate the evaluation and challenges of providing precision fluid and vasoactive therapies to adult critically ill patients. The review includes a discussion of important investigations published after the release of currently available clinical practice guidelines to provide insight into how recommendations and research priorities may change future guidelines and bedside care for critically ill patients.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad Crítica
/
Fluidoterapia
Tipo de estudio:
Guideline
/
Qualitative_research
Límite:
Adult
/
Humans
Idioma:
En
Revista:
Pharmacotherapy
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos